PMID- 21055728 OWN - NLM STAT- MEDLINE DCOM- 20110428 LR - 20191210 IS - 1873-2402 (Electronic) IS - 0006-3223 (Linking) VI - 69 IP - 3 DP - 2011 Feb 1 TI - Cyclic adenosine monophosphate-independent tyrosine phosphorylation of NR2B mediates cocaine-induced extracellular signal-regulated kinase activation. PG - 218-27 LID - 10.1016/j.biopsych.2010.08.031 [doi] AB - BACKGROUND: Activation of the extracellular signal-regulated kinase (ERK) in the striatum is crucial for long-term behavioral alterations induced by drugs of abuse. In response to cocaine, ERK phosphorylation (i.e., activation) is restricted to medium-sized spiny neurons expressing dopamine D1 receptor (D1R) and depends on a concomitant stimulation of D1R and glutamate N-methyl-D-aspartate receptor (NMDAR). However, the mechanisms responsible for this activation, especially the respective contribution of D1R and NMDAR, remain unknown. METHODS: We studied striatal neurons in culture stimulated with D1R agonist and/or glutamate and wild-type or genetically modified mice treated with cocaine. Biochemical, immunohistochemical, and imaging studies were performed. Mice were also subjected to behavioral experiments. RESULTS: Stimulation of D1R cannot activate ERK by itself but potentiates glutamate-mediated calcium influx through NMDAR that is responsible for ERK activation. Potentiation of NMDAR by D1R depends on a cyclic adenosine monophosphate-independent signaling pathway, which involves tyrosine phosphorylation of the NR2B subunit of NMDAR by Src family kinases. We also demonstrate that the D1R/Src family kinases/NR2B pathway is responsible for ERK activation by cocaine in vivo. Inhibition of this pathway abrogates cocaine-induced locomotor sensitization and conditioned place preference. CONCLUSIONS: Our results show that potentiation of NR2B-containing NMDAR by D1R is necessary and sufficient to trigger cocaine-induced ERK activation. They highlight a new cyclic adenosine monophosphate-independent pathway responsible for the integration of dopamine and glutamate signals by the ERK cascade in the striatum and for long-term behavioral alterations induced by cocaine. CI - Copyright A(c) 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved. FAU - Pascoli, Vincent AU - Pascoli V AD - Centre National de la Recherche Scientifique Unite Mixte de Recherche, Paris, France. FAU - Besnard, Antoine AU - Besnard A FAU - Herve, Denis AU - Herve D FAU - Pages, Christiane AU - Pages C FAU - Heck, Nicolas AU - Heck N FAU - Girault, Jean-Antoine AU - Girault JA FAU - Caboche, Jocelyne AU - Caboche J FAU - Vanhoutte, Peter AU - Vanhoutte P LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20101104 PL - United States TA - Biol Psychiatry JT - Biological psychiatry JID - 0213264 RN - 0 (NR2B NMDA receptor) RN - 0 (Phenols) RN - 0 (Piperidines) RN - 0 (Receptors, Dopamine D1) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 0 (Ro 25-6981) RN - 3KX376GY7L (Glutamic Acid) RN - 42HK56048U (Tyrosine) RN - E0399OZS9N (Cyclic AMP) RN - EC 2.7.10.2 (src-Family Kinases) RN - EC 2.7.11.11 (Cyclic AMP-Dependent Protein Kinases) RN - EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases) RN - I5Y540LHVR (Cocaine) RN - SY7Q814VUP (Calcium) SB - IM MH - Animals MH - Calcium/metabolism MH - Cocaine/*pharmacology MH - Conditioning, Psychological/drug effects MH - Corpus Striatum/drug effects/metabolism MH - Cyclic AMP/*metabolism MH - Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors MH - Drug Interactions MH - Extracellular Signal-Regulated MAP Kinases/*metabolism MH - Glutamic Acid/pharmacology MH - Mice MH - Motor Activity/drug effects MH - Neurons/metabolism MH - Phenols/pharmacology MH - Phosphorylation/physiology MH - Piperidines/pharmacology MH - Receptors, Dopamine D1/physiology MH - Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors/*metabolism MH - Signal Transduction/drug effects/physiology MH - Tyrosine/*metabolism MH - src-Family Kinases/metabolism EDAT- 2010/11/09 06:00 MHDA- 2011/04/29 06:00 CRDT- 2010/11/09 06:00 PHST- 2010/03/31 00:00 [received] PHST- 2010/08/11 00:00 [revised] PHST- 2010/08/30 00:00 [accepted] PHST- 2010/11/09 06:00 [entrez] PHST- 2010/11/09 06:00 [pubmed] PHST- 2011/04/29 06:00 [medline] AID - S0006-3223(10)00915-7 [pii] AID - 10.1016/j.biopsych.2010.08.031 [doi] PST - ppublish SO - Biol Psychiatry. 2011 Feb 1;69(3):218-27. doi: 10.1016/j.biopsych.2010.08.031. Epub 2010 Nov 4.